Literature DB >> 3484418

Primary ciliary dyskinesia with transverse colon carcinoma.

J Yoshida, M Tsuneyoshi, K Nakamura, T Murakami, Y Akamine.   

Abstract

Primary ciliary dyskinesia, characterized by chronic airway infection, impaired fertility, and situs inversus in half the number of cases, was detected in a 58-year-old Japanese woman, along with carcinoma of the transverse colon. She was of complete situs inversus and subfertile and had chronic bronchitis and nasal polyposis. Ultrastructurally, the cilia of the nasal mucosa lacked dynein arms. This is the first documentation of this disease coupled with cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3484418     DOI: 10.1093/ajcp/85.1.101

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  A patient of situs ambiguus with pancreatic head cancer successfully treated with gemcitabine and erlotinib.

Authors:  Po-Chou Lin; Jiun-I Lai; Cheng-Hwai Tzeng; Wei-Shu Wang
Journal:  Med Oncol       Date:  2010-01-22       Impact factor: 3.064

2.  Founder mutation(s) in the RSPH9 gene leading to primary ciliary dyskinesia in two inbred Bedouin families.

Authors:  Orit Reish; Montgomery Slatkin; Daphne Chapman-Shimshoni; Arnon Elizur; Barry Chioza; Victoria Castleman; Hannah M Mitchison
Journal:  Ann Hum Genet       Date:  2010-01-08       Impact factor: 1.670

3.  Colorectal cancer and situs inversus totalis: case report.

Authors:  Marcelo Pandolfi Basso; Adriana Borgonovi Christiano; Francisco de Assis Gonçalves-Filho; Marcelo Maia Caixeta de Melo; Luiz Sérgio Ronchi; João Gomes Netinho
Journal:  Arq Bras Cir Dig       Date:  2014 Nov-Dec

4.  Novel alterations in IFT172 and KIFAP3 may induce basal cell carcinoma.

Authors:  Shoko Onodera; Nana Morita; Yuriko Nakamura; Shinichi Takahashi; Kazuhiko Hashimoto; Takeshi Nomura; Akira Katakura; Kenjiro Kosaki; Toshifumi Azuma
Journal:  Orphanet J Rare Dis       Date:  2021-10-21       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.